Prospective Study
Copyright ©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Jun 7, 2014; 20(21): 6658-6665
Published online Jun 7, 2014. doi: 10.3748/wjg.v20.i21.6658
Table 1 Univariate analysis of survival, according to the clinicopathological factors of patients who underwent surgical resection (R0, R1 and R2) for mid-distal extrahepatic bile duct cancer n (%)
VariablesTotal (n = 133)
No.5 yr survivalMedianP value
AgeMean 65.8
≤ 7086 (64.7)39.141.00.917
> 7047 (35.3)44.838.0
SexM81 (60.9)33.636.00.359
F52 (39.1)59.4105.0
CA19-9 (U/mL) ≤ 3527 (30)57.985.00.734
> 3563 (70)44.937.0
Type of resectionPD90 (67.7)47.259.00.105
BDR43 (32.3)30.032.0
T classificationTis, T138 (29.7)52.363.00.144
T225 (19.5)56.8-
T365 (50.8)34.136.0
N classificationN096 (75.0)51.363.00.033
N132 (25.0)17.030.0
M classificationM0130 (97.7)42.241.00.242
M13 (2.3)016.0
TNM stage0, I51 (39.5)64.5105.00.006
II75 (58.1)30.136.0
III0 (0)--
IV3 (2.3)016.0
PNI-75 (58.6)55.8105.00.022
+53 (41.4)17.538.0
LVI-103 (80.5)52.363.00.000
+25 (19.5)6.723.0
Resection marginR0102 (76.7)49.059.00.000
R124 (18.0)21.031.0
R27 (5.3)012.0
DifferentiationPapillary4 (3.2)66.7105.00.409
W/D40 (32.5)48.859.0
M/D66 (53.7)36.736.0
P/D13 (10.6)56.163.0
Table 2 Multivariate analysis of survival according to the clinicopathological factors of patients who underwent surgical resection (R0, R1 and R2) for middle and distal extrahepatic bile duct cancers
VariableHazard ratio95%CIP value
AJCC stage0, I10.023
II4.5721.473-14.183
III--
IV11.1851.061-117.922
LVI-10.002
+2.9421.510-5.733